Nu Skin Enterprises (NYSE:NUS) Given New $6.75 Price Target at Citigroup

Nu Skin Enterprises (NYSE:NUS) had its price objective reduced by analysts at Citigroup from $11.50 to $6.75 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Citigroup’s target price would indicate a potential upside of 10.47% from the stock’s current price.

A number of other equities analysts also recently weighed in on NUS. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Friday, September 6th. DA Davidson dropped their price objective on Nu Skin Enterprises from $12.50 to $11.00 and set a “neutral” rating on the stock in a research note on Monday, August 12th.

Nu Skin Enterprises Stock Performance

Shares of Nu Skin Enterprises stock traded down $0.05 during mid-day trading on Tuesday, hitting $6.11. 403,752 shares of the stock were exchanged, compared to its average volume of 849,153. Nu Skin Enterprises has a 12 month low of $5.99 and a 12 month high of $20.75. The company has a 50-day simple moving average of $7.76 and a 200 day simple moving average of $10.46. The company has a market capitalization of $303.47 million, a P/E ratio of -101.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.33 and a current ratio of 2.12.

Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Thursday, August 8th. The company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.04. Nu Skin Enterprises had a positive return on equity of 7.80% and a negative net margin of 8.05%. The firm had revenue of $439.10 million for the quarter, compared to the consensus estimate of $431.87 million. During the same quarter in the previous year, the business earned $0.54 EPS. The company’s revenue was down 12.2% compared to the same quarter last year. Sell-side analysts anticipate that Nu Skin Enterprises will post 0.78 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Nu Skin Enterprises

Several institutional investors have recently bought and sold shares of NUS. PNC Financial Services Group Inc. raised its holdings in Nu Skin Enterprises by 35.9% during the 4th quarter. PNC Financial Services Group Inc. now owns 10,851 shares of the company’s stock valued at $211,000 after acquiring an additional 2,865 shares during the period. CWM LLC raised its holdings in Nu Skin Enterprises by 38.4% during the 1st quarter. CWM LLC now owns 3,286 shares of the company’s stock valued at $45,000 after acquiring an additional 911 shares during the period. SteelPeak Wealth LLC bought a new stake in Nu Skin Enterprises during the 1st quarter valued at $207,000. Mirae Asset Global Investments Co. Ltd. raised its holdings in Nu Skin Enterprises by 8.6% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,077 shares of the company’s stock valued at $361,000 after acquiring an additional 2,057 shares during the period. Finally, BNP Paribas Financial Markets raised its holdings in Nu Skin Enterprises by 10.9% during the 1st quarter. BNP Paribas Financial Markets now owns 114,326 shares of the company’s stock valued at $1,581,000 after acquiring an additional 11,220 shares during the period. Hedge funds and other institutional investors own 82.84% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.